Inpharma Weekly

, Volume 1497, Issue 1, pp 10–10 | Cite as

Molecular characteristics not indicative of NSCLC survival

News item


Lung Cancer Epidermal Growth Factor Receptor Erlotinib Placebo Recipient England Journal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2005

Personalised recommendations